Sandoz, Brazil

Regional Medical Director – LatAm

Medical degree from Universidade de Sao Paulo, with specialization in Endocrinology and Metabolism and a Ph.D. in endocrine oncology at the same institution. Working in the pharmaceutical industry for 15 years, with special focus in endocrinology, oncology, immunology, biologics and biosimilars. In the last 3 years, supporting the launch of Rituximab, Adalimumab and Etanercept biosimilars from Sandoz over 15 countries in Latin America.

Register for the Biosimilars LatAm – Brazil 2022

Back